Skip to main content
ACHC
NASDAQ Life Sciences

Acadia Lifts FY26 Guidance as Q3 Revenue Grows 5.1% to $895M

Tom Rudovsky · Reported by BusinessWire
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$32.25
Mkt Cap
$3.002B
52W Low
$11.43
52W High
$35.83
52W Position info
182% above low
Off High info
10.0% below high
Rel. Volume info
3.1× avg
Market data snapshot near publication time

ACHC has more than doubled off its 52-week low of $11.43 on elevated volume (3.1× avg).

Summary

Acadia raised full-year 2026 guidance across the board: Adjusted EBITDA to $615-625 million from $590-615 million, and Adjusted EPS to $1.70-1.80 from $1.45-1.60. Q3 revenue rose 5.1% to $895.3 million on same-facility revenue growth of 5.2%, with Acute inpatient revenue up 11.3% offsetting an 8.2% decline in Specialty. Adjusted EBITDA was $176.4 million versus $173.0 million a year ago, while Adjusted EPS fell to $0.60 from $0.72 on higher taxes and costs, and GAAP EPS came in at 38 cents. Management also flagged roughly $60 million of incremental EBITDA expected in 2027 from the 16 acute facilities opened over the past four years. The quarter included a $13.4 million favorable Florida supplemental payment accrual versus $5.6 million previously guided, which flatters the EBITDA beat. This follows the September 25 8-K on preliminary approval of the $12 million derivative settlement, with a final hearing set for December. Q3 earnings call is November 5 at 9:00 a.m. ET.

At the time of this announcement, ACHC was trading at $32.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3B. The 52-week trading range was $11.43 to $35.83. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

ACHC - Latest Insights

ACHC
Jul 28, 2026, 4:57 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $31.00
Real-time Price: $34.40 info
Change: +$3.40 (+11%) info
Market Cap: $3.239B info
ACHC
Jul 28, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $31.00
Real-time Price: $34.40 info
Change: +$3.40 (+11%) info
Market Cap: $3.239B info
ACHC
Jul 28, 2026, 4:24 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $30.99
Real-time Price: $34.40 info
Change: +$3.41 (+11%) info
Market Cap: $3.239B info
ACHC
May 18, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $25.30
Real-time Price: $34.40 info
Change: +$9.10 (+36%) info
Market Cap: $3.239B info
ACHC
Apr 30, 2026, 6:11 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $26.97
Real-time Price: $34.40 info
Change: +$7.43 (+28%) info
Market Cap: $3.239B info